ICM
PGNY icon

Invenomic Capital Management’s Progyny PGNY Stock Holding History

Invenomic Capital Management’s Portfolio PGNY Stock Details PGNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-340,668
Closed -$7.61M – 185
2025
Q1 		$7.61M Sell
340,668
-1,281,461
-79% -$27.6M 0.38% 89
2024
Q4 		$28M Sell
1,622,129
-138,577
-8% -$2.15M 1.33% 17
2024
Q3 		$29.5M Buy
+1,760,706
New +$42.3M 1.62% 14

Other funds holding PGNY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invenomic Capital Management's PGNY Position: Q2 2025 in Review

Invenomic Capital Management sold out of Progyny (PGNY) in Q2 2025, closing a stake of 340,668 shares — an estimated $7.61M sold.

Invenomic Capital Management first reported a position in PGNY in Q3 2024 and held it in 3 quarters. The position peaked at $29.5M in Q3 2024. 302 funds tracked by Wall St. Rank hold PGNY as of Q2 2025.

  • Invenomic Capital Management reported no remaining Progyny position as of Q2 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 340,668 Progyny shares in Q2 2025, an estimated $7.61M.
  • Invenomic Capital Management first reported a position in Progyny in Q3 2024 and held it in 3 quarters.
  • Invenomic Capital Management's Progyny position peaked at $29.5M in Q3 2024.
  • 302 funds tracked by Wall St. Rank held Progyny as of Q2 2025.

Based on Invenomic Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.